Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments
Tóm tắt
In hepatobiliary imaging, systems detect the total amount of agents originating from extracellular space, bile canaliculi, and hepatocytes. They add in situ concentration of each compartment corrected by its respective volume ratio to provide liver concentrations. In vivo contribution of each compartment to liver concentration is inaccessible. Our aim was to quantify the compartmental distribution of two hepatobiliary agents in an ex vivo model and determine how their liver extraction ratios and cholestasis (livers lacking canalicular transporters) might modify it. We perfused labelled gadobenate dimeglumine (Bopta, 200 μM, 7% liver extraction ratio) and mebrofenin (Meb, 64 μM, 94% liver extraction ratio) in normal (n = 18) and cholestatic (n = 6) rat livers. We quantified liver concentrations with a gamma counter placed over livers. Concentrations in hepatocytes and bile canaliculi were calculated. Mann-Whitney and Kruskal-Wallis tests were used. Hepatocyte concentrations were 2,043 ± 333 μM (Meb) versus 360 ± 69 μM (Bopta, p < 0.001). Meb extracellular concentrations did not contribute to liver concentrations (1.3 ± 0.3%). The contribution of Bopta extracellular concentration was 12.4 ± 1.9% (p < 0.001 versus Meb). Contribution of canaliculi was similar for both agents (16%). Cholestatic livers had no Bopta in canaliculi but their hepatocyte concentrations increased in comparison to normal livers. Hepatocyte concentrations are correlated to liver extraction ratios of hepatobiliary agents. When Bopta is not present in canaliculi of cholestatic livers, hepatocyte concentrations increase in comparison to normal livers. This new understanding extends the interpretation of clinical liver images.
Tài liệu tham khảo
Pastor CM, Mullhaupt B, Stieger B (2014) The role of organic anion transporters in diagnosing liver diseases by magnetic resonance imaging. Drug Metab Dispos 42:675–684. https://doi.org/10.1124/dmd.113.055707
Kusuhara H (2013) Imaging in the study of membrane transporters. Clin Pharmacol Ther 94:33–36. https://doi.org/10.1038/clpt.2013.85
Guo Y, Chu X, Parrott NJ, et al (2018) Advancing predictions of tissue and intracellular drug concentrations using in vitro, imaging and PBPK modeling approaches. Clin Pharmacol Ther 104:865–889. https://doi.org/10.1002/cpt.1183
de Graaf W, Bennink RJ, Vetelainen R, van Gulik TM (2010) Nuclear imaging techniques for the assessment of hepatic function in liver surgery and transplantation. J Nucl Med 51:742–752. https://doi.org/10.2967/jnumed.109.069435
Bastati N, Beer L, Mandorfer M, et al (2020) Does the functional liver imaging score derived from Gadoxetic acid-enhanced MRI predict outcomes in chronic liver disease? Radiology 294:98–107. https://doi.org/10.1148/radiol.2019190734
Hoekstra LT, de Graaf W, Nibourg GA et al (2013) Physiological and biochemical basis of clinical liver function tests: a review Ann Surg 257:27–36. https://doi.org/10.1097/SLA.0b013e31825d5d47
Ba-Ssalamah A, Bastati N, Wibmer A, et al (2017) Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: where are we? J Magn Reson Imaging 45:646–659. https://doi.org/10.1002/jmri.25518
Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429. https://doi.org/10.1016/j.jhep.2012.01.031
Vilgrain V, Van Beers BE, Pastor CM (2016) Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRI. J Hepatol 64:708–716. https://doi.org/10.1016/j.jhep.2015.11.016
Vander Borght S, Libbrecht L, Blokzijl H, et al (2005) Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. J Pathol 207:471–482. https://doi.org/10.1002/path.1852
Sourbron S (2014) A tracer-kinetic field theory for medical imaging. IEEE Trans Med Imaging 33:935–946. https://doi.org/10.1109/TMI.2014.2300450
Zhou IY, Catalano OA, Caravan P (2020) Advances in functional and molecular MRI technologies in chronic liver diseases. J Hepatol 73:1241–1254. https://doi.org/10.1016/j.jhep.2020.06.020
Poetter-Lang S, Bastati N, Messner A, et al (2020) Quantification of liver function using gadoxetic acid-enhanced MRI. Abdom Radiol (NY) 45:3532–3544. https://doi.org/10.1007/s00261-020-02779-x
Pastor CM (2018) Isolated perfused rat livers to quantify the pharmacokinetics and concentrations of Gd-BOPTA. Contrast Media Mol Imaging 2018:3839108–3839111. https://doi.org/10.1155/2018/3839108
Bonnaventure P, Cusin F, Pastor CM (2019) Hepatocyte concentrations of imaging compounds associated with transporter inhibition: evidence in perfused rat livers. Drug Metab Dispos 47:412–418. https://doi.org/10.1124/dmd.118.084624
Millet P, Moulin M, Stieger B, Daali Y, Pastor CM (2011) How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver. J Pharmacol Exp Ther 336:624–632. https://doi.org/10.1124/jpet.110.175406
Pastor CM, Planchamp C, Pochon S, et al (2003) Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Radiology 229:119–125. https://doi.org/10.1148/radiol.2291020726
Cavagna FM, Maggioni F, Castelli PM et al (1997) Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780–796. https://doi.org/10.1097/00004424-199712000-00009
Ghibellini G, Leslie EM, Pollack GM, Brouwer KL (2008) Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies. Pharm Res 25:1851–1860. https://doi.org/10.1007/s11095-008-9597-0
Blouin A, Bolender RP, Weibel ER (1977) Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol 72:441–455. https://doi.org/10.1083/jcb.72.2.441
Hinge function (2021) GraphPad software, La Jolla California, USA:https://www.graphpad.com/guides/prism/latest/curve-fitting/reg_equation-hinge-function.htm?q=hinge+function
Segmental linear regression (2021) GraphPad software, La Jolla California, USA:https://www.graphpad.com/guides/prism/latest/curve-fitting/reg_segmental_linear_regression.htm
Schmitz SA, Mühler A, Wagner S, Wolf KJ (1996) Functional hepatobiliary imaging with Gd-EOB-DTPA. A comparison of magnetic resonance imaging and 153Gd-EOB-DTPA scintigraphy in rats. Invest Radiol 31:154–160. https://doi.org/10.1097/00004424-199603000-00006
Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183:59–64. https://doi.org/10.1148/radiology.183.1.1549695
Frydrychowicz A, Lubner MG, Brown JJ, et al (2012) Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging 35:492–511. https://doi.org/10.1002/jmri.22833
Saito S, Obata A, Kashiwagi Y, Abe K, Murase K (2013) Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA. Invest Radiol 48:548–553. https://doi.org/10.1097/RLI.0b013e3182856a06
Truhn D, Kuhl CK, Ciritsis A, Barabasch A, Kraemer NA (2019) A new model for MR evaluation of liver function with Gadoxetic acid, including both uptake and excretion. Eur Radiol 29:383–391. https://doi.org/10.1007/s00330-018-5500-5
Nilsson H, Nordell A, Vargas R, Douglas L, Jonas E, Blomqvist L (2009) Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI. J Magn Reson Imaging 29:1323–1331. https://doi.org/10.1002/jmri.21801
Ronot M, Leporq B, Van Beers BE, Vilgrain V (2019) CT and MR perfusion techniques to assess diffuse liver disease. Abdom Radiol (NY). 45:3496–3506. https://doi.org/10.1007/s00261-019-02338-z
Saito K, Ledsam J, Sourbron S, et al (2013) Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. J Magn Reson Imaging 37:1109–1114. https://doi.org/10.1002/jmri.23907
Planchamp C, Gex-Fabry M, Becker CD, Pastor CM (2007) Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers. Invest Radiol 42:513–521. https://doi.org/10.1097/RLI.0b013e318036b450
Pastor CM, Wissmeyer M, Millet P (2013) Concentrations of Gd-BOPTA in cholestatic fatty rat livers: role of transport functions through membrane proteins. Contrast Media Mol Imaging 8:147–156. https://doi.org/10.1002/cmmi.1511